Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · HealthEquity (HQY)

HealthEquity Q3 revenue rises 7% to $322.2 million; net income $51.7 million

Positive Impact 3 of 5 earnings Written later

HealthEquity reported results for its fiscal third quarter ended October 31, 2025, with revenue up 7% year over year and GAAP net income of $51.7 million, compared with $5.7 million a year earlier. The company also gave fiscal 2026 outlook, expecting revenue of $1.302 billion to $1.312 billion and GAAP net income of $2.24 to $2.33 per diluted share.

Key points

  • Q3 revenue was $322.2 million, up from $300.4 million a year earlier.
  • GAAP net income per diluted share was $0.59, versus $0.06 a year earlier; non-GAAP net income per diluted share rose 29% to $1.01.
  • Adjusted EBITDA was $141.8 million, up 20% year over year.
  • For the fiscal year ending January 31, 2026, the company expects non-GAAP net income per diluted share of $3.87 to $3.95.

The filing

CompanyHealthEquity (HQY)
Form8-K, current report
Filed with the SECDec 3, 2025, 4:02 PM ET
Accession number0001428336-25-000035

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:17 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on December 03, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.